Pfizer Pharmaceuticals LLC
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$196Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
975clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Luis Garcia Barreto | Coamo, PR | Pulmonary Disease | $34,849.90 |
| Alejandro Lopez Mas | Ponce, PR | Interventional Cardiology | $25,779.54 |
| Luis Gely | Caguas, PR | Cardiovascular Disease | $16,694.17 |
| Iris Cardona | Carolina, PR | Pediatrics | $15,811.61 |
| Cristina Ramos | San Juan, PR | Allergy & Immunology | $9,401.28 |
| Antonio Renta Munoz | Hato Rey, PR | $8,773.23 | |
| Norma Devarie Diaz | San Juan, PR | $5,853.25 | |
| Sonia Vicenty | San Juan, PR | Cardiovascular Disease | $5,050.00 |
| Hector Lozano | San Juan, PR | Gastroenterology (Internal Medicine) | $4,471.11 |
| Luis Ortiz Espinosa | Bayamon, PR | Dermatology | $4,261.75 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.